Stocks and Investing
Stocks and Investing
Mon, August 14, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kevin Steinke Maintained (CCRN) at Buy with Decreased Target to $29 on, Aug 14th, 2023
Kevin Steinke of Barrington Research, Maintained "Cross Country Healthcare, Inc." (CCRN) at Buy with Decreased Target from $35 to $29 on, Aug 14th, 2023.
Kevin has made no other calls on CCRN in the last 4 months.
There are 3 other peers that have a rating on CCRN. Out of the 3 peers that are also analyzing CCRN, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $26 on, Tuesday, August 8th, 2023
- Tobey Sommer of "Truist Securities" Maintained at Hold with Decreased Target to $25 on, Tuesday, May 2nd, 2023
This is the rating of the analyst that currently disagrees with Kevin
- Trevor Romeo of "William Blair" Initiated at Buy on, Monday, June 26th, 2023
Contributing Sources